Lisinopril dihydrate
A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.Hypertension Approved (In Vitro) :Lisinopri dihydrate is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII) . ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS) . Lisinopril may be used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals following myocardial infarction, and to prevent progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.
Product Specifications
CAS Number
83915-83-7
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: < 4.4 mg/mL
Smiles
C1C[C@H] (N (C1) C (=O) [C@H] (CCCCN) N[C@@H] (CCC2=CC=CC=C2) C (=O) O) C (=O) O.O.O
Molecular Formula
C21H35N3O7
Molecular Weight
441.5185
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
L-Proline, N2-[ (1S) -1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SOX2 (Embryonic Stem Cell Marker) (SOX2/3169R), CF405S conjugate, 0.1mg/mL
